Sigma-Aldrich

Sigma-Aldrich is a prominent life science and high technology company that specializes in providing a wide range of organic chemical products, kits, and services. These offerings are integral to scientific research, biotechnology, pharmaceutical development, and disease diagnosis, playing a crucial role in advancing scientific breakthroughs. The company's products are also essential components in various manufacturing processes within the pharmaceutical and diagnostic sectors, as well as other high-tech industries. Operating in 40 countries, Sigma-Aldrich employs around 7,600 individuals dedicated to delivering high-quality solutions and excellent service to clients worldwide.

Benoit Gourdier

Senior VP and General Manager BioReliance Testing Services

8 past transactions

HUB Organoids

Acquisition in 2024
HUB Organoids specializes in creating patient-derived organ models to predict responses to treatments and enhance drug development processes. The company offers preclinical services, custom model development, and a licensing program for its organoid technology.

Mirus Bio

Acquisition in 2024
Mirus Bio specializes in providing gene transfer technologies for the pharmaceutical industry, focusing on the development of innovative nucleic acid-based solutions. The company has developed a proprietary RNAi (Ribonucleic Acid Interference) delivery platform that equips life scientists with advanced tools for various applications, including gene expression, biotherapeutic protein production, virus manufacturing, and genome editing. Through its commitment to innovation, Mirus Bio aims to enhance the capabilities of researchers and contribute to advancements in biotechnology.

Erbi Biosystems

Acquisition in 2022
Erbi Biosystems, Inc. specializes in developing innovative microbioreactor technology solutions aimed at automating the study of microorganisms. The company offers a range of products, including microbioreactor devices, disposable fluid sources, control modules, and system software. These systems are designed to streamline and standardize complex cell culture processes, facilitating basic research, bioprocess characterization, and optimization while reducing variability between experiments. Founded in 2006 and based in Woburn, Massachusetts, Erbi Biosystems was previously known as Pharyx, Inc. before rebranding in January 2019. The company's microfluidic bioprocess instrumentation is intended to enhance research capabilities, particularly in areas such as cell-based cancer immunotherapies and parallel anaerobic fermentations.
The MAST platform is an automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities for more efficient and cost-effective drug manufacturing.

AmpTec

Acquisition in 2021
AmpTec is an international provider of RNA technology products, specializing in RNA isolation, mRNA amplification kits, and the production of synthetic long RNAs and DNAs. The company focuses on polymerase chain reaction-based technologies for mRNA manufacturing, which are essential for developing therapeutics. In addition to its core offerings, AmpTec also manufactures lipids and provides customized long RNAs and DNAs for in vitro diagnostics. The company is dedicated to engaging directly with life science industries and academic research institutions globally, offering on-site technical support to enhance customer interactions.

Flodesign Sonics

Acquisition in 2019
FloDesign Sonics is changing the separations and filtration markets through a novel acoustic technology. By leveraging breakthroughs in the use of 3D acoustic standing waves, FloDesign Sonics is able to capture, separate and purify without using physical membranes, chemicals, or centrifugation. Our proprietary technology has numerous applications in a variety of markets including life sciences, oil and gas, food and beverage and industrial processing. The first commercial application is in bioprocess separations where FloDesign Sonics is applying acoustic technology to the manufacturing of life saving bio-pharmaceuticals. For more information, contact info@fdsonics.com

Cell Marque

Acquisition in 2014
Cell Marque is a quality supplier of a most valuable and innovative portfolio of antibodies suitable for immunohistochemistry on both frozen and FFPE sections. Our main focus is on in vitro diagnostics and we are pleased to have introduced over 70 additional antibodies in 2008-2009 to further serve the clinical market. It is our job to supply you with the latest and most useful antibodies to help you succeed in offering the best care for your patients. We bring you dedication that can only come from a company whose focus is primarily on antibodies.

ChemNavigator

Acquisition in 2009
ChemNavigator.com, Inc. is a provider of tools and services aimed at assisting scientists in the identification and procurement of chemical compounds essential for drug discovery and agrochemical research. Founded in 1999 and based in San Diego, California, the company offers a comprehensive database that includes a wide array of chemical products, from drug-like compounds for molecular screening to synthetic building blocks for chemical synthesis. This database facilitates chemical data analysis and compound selection, thereby enabling researchers in medicinal, computational, and synthetic chemistry, as well as professionals in chemical procurement, to efficiently select and acquire novel chemical products for their research needs. As of August 2009, ChemNavigator operates as a subsidiary of Sigma-Aldrich Corporation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.